Drug Master Files, manufacturer listings, and Electronic Common Technical Document (eCTD) submissions are foundational to regulatory compliance. Yet even experienced regulatory, quality, and operations...
The global Unique Device Identification (UDI) landscape is entering a critical enforcement phase — and 2026 will be a challenging year for medical device manufacturers operating in the European Union...
The FDA’s final rule, “Revising the National Drug Code Format and Drug Label Barcode Requirements,” establishes a uniform 12-digit format for FDA-assigned National Drug Codes (NDCs) ...
UDI product data is now due for specific scenarios (enforced as of December 8, 2022). Class I and Unclassified medical devices that are required to be labeled with a UDI code must submit product data...
LexisNexis Life Sciences Solutions and ONIX expand strategic alliance to guide pharma customers to market faster Professionals in the life sciences industry rely on unique regulatory affairs expertise...
Swissmedic has launched the Unique Device Identification (UDI) module within the swissdamed database (Swiss Database on Medical Devices). Since August 2025, manufacturers, importers, and authorized representatives can voluntarily submit medical devices, systems, and procedure packs into swissdamed.
This launch marks a major step in Switzerland’s medical device regulatory framework. It also brings swissdamed closer to the European Union’s EUDAMED system. The UDI module will improve traceability, increase transparency, and strengthen post-market surveillance.
The UDI module represents a significant regulatory advancement for Switzerland. Although participation is voluntary now, early engagement will ease adoption once registration becomes mandatory.
Organizations should:
Proactive involvement during the voluntary phase will reduce operational risks, highlight technical challenges, and ensure readiness for the 2026 compliance deadlines.
For further guidance on preparing for swissdamed and leveraging existing EUDAMED processes, download our comprehensive EUDAMED whitepaper.
Learn More
Contact us